doi: 10.1007/s40572-021-00328-2
The introduction of the GLP-1 class of medications for weight loss has, to date, been one of the rockiest rollouts of a major medical advance in the United States
Smeekens JM, Kesselring JR, Bagley K, Kulis MD (2024) A mouse model of shrimp allergy with cross-reactivity to crab and lobster
The label on these medications, for example, Wegovy, clearly states that the drug has not been evaluated in patients with type 1 diabetes or in combination with insulin [9]
GNC Glutathione may interact with certain medications
Managing dysbiosis often involves microbiota-directed therapies, such as probiotics, prebiotics, smart microbiota modulation, and fecal microbiota transplantation, as alterations in the microbiome are linked to chronic diseases